Henan Lingrui Pharmaceutical Co (SHSE:600285) Cyclically Adjusted Book per Share: ¥4.55 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600285 Henan Lingrui Pharmaceutical Co Ltd SHSE:600285
96 GF Score
Price ¥20.08
GF Value ¥23.72
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Henan Lingrui Pharmaceutical Co Cyclically Adjusted Book per Share?

Henan Lingrui Pharmaceutical Co SHSE:600285 +0.96% 96 Cyclically Adjusted Book per Share is ¥4.55 as of Jun. 2026. GuruFocus rates SHSE:600285 with a GF Score™ of 96/100 and a GF Value™ of ¥23.72 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Henan Lingrui Pharmaceutical Co's adjusted book value per share for the three months ended in Jun. 2026 was ¥5.698. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥4.55 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Henan Lingrui Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 6.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 7.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 8.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Henan Lingrui Pharmaceutical Co was 10.70% per year. The lowest was 1.60% per year. And the median was 7.40% per year.

As of today (2026-08-28), Henan Lingrui Pharmaceutical Co's current stock price is ¥20.08. Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ¥4.55. Henan Lingrui Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 4.41.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Henan Lingrui Pharmaceutical Co was 6.32. The lowest was 2.49. And the median was 4.14.


Henan Lingrui Pharmaceutical Co  (SHSE:600285) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Henan Lingrui Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=20.08/4.55
=4.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Henan Lingrui Pharmaceutical Co was 6.32. The lowest was 2.49. And the median was 4.14.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Henan Lingrui Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Henan Lingrui Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henan Lingrui Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Henan Lingrui Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.38 3.69 3.94 4.19 4.42

Henan Lingrui Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.27 4.35 4.42 4.52 4.55

SHSE:600285 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Henan Lingrui Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henan Lingrui Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Henan Lingrui Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Henan Lingrui Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600285
96GF Score
Henan Lingrui Pharmaceutical Co Ltd SHSE:600285
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Henan Lingrui Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Henan Lingrui Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=5.698/116.0564*116.0564
=5.698

Current CPI (Jun. 2026) = 116.0564.

Henan Lingrui Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 3.500 102.400 3.967
201612 3.524 102.600 3.986
201703 3.651 103.200 4.106
201706 3.591 103.100 4.042
201709 3.692 104.100 4.116
201712 3.671 104.500 4.077
201803 3.742 105.300 4.124
201806 3.566 104.900 3.945
201809 3.605 106.600 3.925
201812 3.651 106.500 3.979
201903 3.762 107.700 4.054
201906 3.807 107.700 4.102
201909 3.906 109.800 4.129
201912 3.892 111.200 4.062
202003 4.019 112.300 4.153
202006 3.856 110.400 4.054
202009 3.999 111.700 4.155
202012 4.073 111.500 4.239
202103 4.267 112.662 4.396
202106 3.780 111.769 3.925
202109 3.951 112.215 4.086
202112 4.014 113.108 4.119
202203 4.282 114.335 4.346
202206 4.026 114.558 4.079
202209 4.310 115.339 4.337
202212 4.495 115.116 4.532
202303 4.758 115.116 4.797
202306 4.482 114.558 4.541
202309 4.780 115.339 4.810
202312 4.921 114.781 4.976
202403 5.173 115.227 5.210
202406 4.766 114.781 4.819
202409 5.103 115.785 5.115
202412 5.418 114.893 5.473
202503 5.839 115.116 5.887
202506 5.407 114.907 5.461
202509 5.728 115.471 5.757
202512 5.996 115.832 6.008
202603 6.434 116.303 6.420
202606 5.698 116.056 5.698

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥4.55 mean?
Henan Lingrui Pharmaceutical Co (SHSE:600285) has a Cyclically Adjusted Book per Share of ¥4.55 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Henan Lingrui Pharmaceutical Co and its competitors.
Is Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Henan Lingrui Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥4.55. Overall, Henan Lingrui Pharmaceutical Co has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS?
Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Book per Share of ¥4.55 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Henan Lingrui Pharmaceutical Co and its competitors. Henan Lingrui Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥4.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henan Lingrui Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co (SHSE:600285) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥23.72, compared to a current price of ¥20.08 — trading 15.3% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥4.55. Henan Lingrui Pharmaceutical Co's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Henan Lingrui Pharmaceutical Co (SHSE:600285), the current Cyclically Adjusted Book per Share is ¥4.55 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Henan Lingrui Pharmaceutical Co (SHSE:600285) Overvalued in 2026?

Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥20.08 is trading 15.3% below its estimated GF Value™ of ¥23.72. GuruFocus considers Henan Lingrui Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:600285:

  • Cyclically Adjusted Book per Share: ¥4.55
  • GF Value™: ¥23.72 vs. price of ¥20.08 (15.3% below fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Henan Lingrui Pharmaceutical Co Business Description

Address No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
96GF Score

Get the complete analysis for SHSE:600285

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.08
Price
¥23.72
GF Value